ModelEdge

Intercept Pharmaceuticals, Inc.
ICPT
Filing Type8-K
Filing Date11/7/2023
Updated11/8/23, 9:44 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in
EX-3.1EXHIBIT 3.1
EX-3.2EXHIBIT 3.2
EX-4.1EXHIBIT 4.1
EX-4.2EXHIBIT 4.2
EX-99.1Material Contracts, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in
EX-99.2Material Contracts, Completing Asset Acquisition or Sale, Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in